營養保健品和疫苗市場規模、佔有率和成長分析（按產品類型、應用、配方類型、配銷通路和地區）- 2025-2032 年行業預測

2023 年全球膳食補充劑和疫苗市場規模價值 570.4 億美元，預計將從 2024 年的 613.8 億美元成長到 2032 年的 1102.8 億美元，預測期內（2025-2032 年）的複合年成長率為 7.6%。

受消費者意識增強和對健康和保健日益關注的推動，全球膳食補充劑和疫苗市場正在經歷強勁成長。營養保健食品，包括機能性食品和膳食補充劑，因其預防性保健功效而越來越受到追捧。同時，在疫苗技術進步和世衛組織全球疫苗行動計劃等鼓勵全民接種疫苗的舉措支持的綜合免疫計劃的推動下，疫苗行業正在蓬勃發展。在政府和非政府組織的支持下，疫苗接種的激增正在增強整體公共衛生能力並推動市場成長。膳食補充劑在預防高血壓和糖尿病等疾病方面發揮著重要作用，其需求不斷增加，反映了社會向主動健康管理的轉變，最終導致醫療成本降低和健康狀況改善。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析

營養保健品和疫苗市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概況
• 疫苗
• 營養補充品

營養保健品和疫苗市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 運動營養
• 一般健康
• 免疫和消化健康
• 骨骼和關節健康
• 心臟健康
• 疾病預防
• 體重減輕

營養保健品和疫苗市場規模（按配方類型和複合年成長率） (2025-2032)

• 市場概況
• 藥片
• 膠囊
• 粉末
• 液體

保健食品和疫苗市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 醫院藥房
• 零售藥局
• 網上銷售
• 超級市場

營養保健品及疫苗市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• GlaxoSmithKline plc（GSK）（United Kingdom）
• Pfizer Inc.（United States）
• Sanofi Pasteur（France）
• Merck & Co., Inc.（United States）
• Moderna, Inc.（United States）
• Novavax, Inc.（United States）
• CSL Limited（Australia）
• AstraZeneca plc（United Kingdom）
• Johnson & Johnson（United States）
• Bavarian Nordic A/S（Denmark）

結論和建議

Global Nutraceutical &Vaccine Market size was valued at USD 57.04 billion in 2023 and is poised to grow from USD 61.38 billion in 2024 to USD 110.28 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global nutraceutical and vaccine market is experiencing robust growth propelled by heightened consumer awareness and a growing focus on health and wellness. Nutraceuticals, including functional foods and dietary supplements, are increasingly sought after for their preventive health benefits. Simultaneously, the vaccine sector is booming due to advancements in vaccine technology and comprehensive immunization programs, supported by initiatives like WHO's Global Vaccine Action Plan, which encourages universal vaccination access. This surge in immunization, backed by both government and NGO involvement, is enhancing overall public health and fostering market growth. The increasing demand for nutraceuticals, recognized for their role in preventing diseases such as hypertension and diabetes, mirrors society's shift towards proactive health management, ultimately reducing healthcare costs and promoting well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutraceutical &Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical &Vaccine Market Segments Analysis

Global Nutraceutical & Vaccine Market is segmented by Product Type, Application, Formulation Type, Distribution Channel and region. Based on Product Type, the market is segmented into Vaccines and Dietary Supplements. Based on Application, the market is segmented into Sports Nutrition, General Well-Being, Immune & Digestive Health, Bone & Joint Health, Heart Health, Disease Prevention and Weight loss. Based on Formulation Type, the market is segmented into Tablets, Capsules, Powders and Liquids. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Sales and Super Markets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nutraceutical &Vaccine Market

A key driver in the global nutraceutical and vaccine market is the heightened focus on preventive healthcare. As awareness of the significance of overall well-being and disease prevention expands, there is a growing demand for products that provide health benefits and bolster the immune system. Consumers are increasingly turning to nutraceuticals and vaccines to adopt a proactive approach to their health. This trend is propelled by various factors, including changing lifestyles, an aging population, and the collective desire to cut healthcare costs by prioritizing disease prevention over treatment. This shift underscores the market's potential for growth and innovation.

Restraints in the Global Nutraceutical &Vaccine Market

A significant challenge facing the global nutraceutical and vaccine market is the stringent regulatory frameworks and approval processes that govern their development and commercialization. These regulations mandate extensive testing, clinical trials, and regulatory clearances to ensure that products meet required safety, efficacy, and quality standards. Such rigorous procedures can often be lengthy and expensive, creating obstacles for market participants, particularly smaller companies with constrained resources. Additionally, these stringent requirements can lead to delays in product launches and heightened compliance costs, ultimately stifling growth and innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical &Vaccine Market

A significant market trend in the global nutraceutical and vaccine sector is the rising demand for personalized and targeted healthcare solutions. Consumers are becoming more health-conscious and are actively seeking products specifically designed to meet their unique health needs and genetic profiles. This trend is primarily driven by technological advancements in genomics, personalized medicine, and data analytics, enabling the creation of customized nutrition and vaccination options. Industry players are increasingly investing in the development of tailored nutraceuticals and vaccines, offering bespoke formulations that cater to individual health concerns and enhance therapeutic outcomes. This movement signifies a pivotal shift towards precision healthcare, acknowledging the importance of individual health variations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Nutraceutical & Vaccine Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Vaccines
• Dietary Supplements

Global Nutraceutical & Vaccine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Sports Nutrition
• General Well-Being
• Immune & Digestive Health
• Bone & Joint Health
• Heart Health
• Disease Prevention
• Weight loss

Global Nutraceutical & Vaccine Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Tablets
• Capsules
• Powders
• Liquids

Global Nutraceutical & Vaccine Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Super Markets

Global Nutraceutical & Vaccine Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Formulation Type, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Formulation Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Formulation Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Formulation Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Formulation Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline plc (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations